• 1
    Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 110723.
  • 2
    Cowell JK. Double minutes and homogeneously staining regions: gene amplification in mammalian cells. Annu Rev Genet 1982; 16: 2159.
  • 3
    Amler L.C., Schwab M. Amplified MYCN in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol 1989; 9: 490313.
  • 4
    Fakharzadeh SS, Rosenblum-Vos L, Murphy M, Hoffmann EK, George DL. Structure and organization of amplified DNA on double minutes containing the MDM2 oncogene. Genomics 1993; 15: 28390.
  • 5
    Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA. Comparative genomic hybridization in glioma. A meta-analysis of 509 cases. Cancer Genet Cytogenet 2002; 135: 14759.
  • 6
    Liu L, Ichimura K, Pettersson EH, Goike HM, Collins VP. The complexity of the 7p12 amplicon in human astrocytic gliomas: detailed mapping of 246 tumors. J Neuropathol Exp Neurol 2000; 59: 108793.
  • 7
    Eley GD, Reiter JL, Pandita A, Park S, Jenkins RB, Maihle NJ, James CD. A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neurooncology 2002; 4: 8694.
  • 8
    Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996; 56: 51415.
  • 9
    Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ, van Dekken H. Genetic aberrations in oligodendroglial tumors: an analysis using comparative genomic hybridization (CGH). J Pathol 1999; 188: 2828.
  • 10
    Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson N, Malfoy B, Dutrillaux B. Oncogene amplification in human gliomas: a molecular cytogenetic analysis. Oncogene 1994; 9: 271722.
  • 11
    Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert M C, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 1994; 144: 120318.
  • 12
    Riemenschneider MJ, Büschges R, Wolter M, Reifenberger J, Boström J, Kraus JA, Schlegel U, Reifenberger G. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 1999; 59: 60916.
  • 13
    Rickman DS, Tyagi R, Zhu XX, Bobek MP, Song S, Blaivas M, Misek DE, Israel MA, Kurnit DM, Ross DA, Kish PE, Hanash SM, et al. The gene for the axonal adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas. Cancer Res 2001; 61: 21628.
  • 14
    KleihuesP, CavaneeWK (eds). Pathology and genetics of tumors of the nervous system, World Health Organization classification of tumors. Lyon: IARC Press, 2000. 2964.
  • 15
    Knobbe CB, Reifenberger G. Molecular genetic analysis of human glioblastomas for aberrations of genes encoding members of the Pten/PI3K/Akt signal transduction pathway. Neurooncol 2001; 3: 304 (abstract).
  • 16
    Ichimura K, Schmidt EE, Goike HM, Collins VP. Human glioblastomas with no alterations of the CDKN2A (p16INK4a, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996; 13: 106572.
  • 17
    Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989. 9.179.19.
  • 18
    Cobbers JMJL, Wolter M, Reifenberger J, Ring GU, Jessen F, An HX, Niederacher D, Schmidt EE, Ichimuar K, Floeth F, Kirsch L, Borchard F, et al. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol 1998; 8: 26376.
  • 19
    Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oord W, Hateboer G, van der Eb AJ, Jochemsen AG. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 1996; 15: 534957.
  • 20
    Shvarts A, Bazuine M, Dekker P, Ramos YFM, Steegenga WT, Merckx G, van Ham RC, van der Houven van Oord W, van der Eb AJ, Jochemsen AG. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics 1997; 43: 3442.
  • 21
    Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett 1999; 447: 59.
  • 22
    Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG, Lozano G. Rescue of embryonic lethality in MDM4-null mice by loss of Trp53 suggests a nonoverlapping pathway with Mdm2 to regulate p53. Nat Genet 2001; 92: 925.
  • 23
    Actor B, Cobbers JMJL, Bueschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 2002; 34: 41627.
  • 24
    Almeida A, Zhu XX, Vogt N, Tyagi R, Muleris M, Dutrillaux AM, Dutrillaux B, Ross D, Malfoy B, Hanash S. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas. Oncogene 1999; 16: 2997-3002.
  • 25
    Knobbe CB, Merlo A, Reifenberger G. Pten signaling in gliomas. Neurooncology 2002; 4: 196211.
  • 26
    Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP, Alessi DR. Identification of pleckstrin-homology-domain containing proteins with novel phosphoinositide-binding specifities. Biochem J 2000; 351: 1931.
  • 27
    Tsiotra PC, Karagogeos D, Theodorakis K, Michaelidis TM, Modi WS, Furley AJ, Jessell TM, Papamatheakis J. Isolation of the cDNA and chromosomal localization of the gene (TAX1) encoding the human axonal glycoprotein TAG-1. Genomics 1993; 18: 5627.
  • 28
    Furley, AJ, Morton SB, Manalo D, Karagogeos D, Dodd J, Jessell TM. The axonal glycoprotein TAG-1 is an immunoglobulin super family member with neurite outgrowth-promoting activity. Cell 1990; 61: 15770.
  • 29
    Tymms MJ, Ng AYN, Thomas RS, Schutte BC, Zhou J, Eyre HJ, Sutherland GR, Seth A, Rosenberg M, Papas T, Debouck C, Kola I. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene 1997; 15: 244962.
  • 30
    Giovane A, Sobieszczuk P, Mignon C, Mattei MG, Wasylyk B. Locations of the ets subfamily members net, elk1, and sap1 (ELK3, ELK1, and ELK4) on 3 homologous regions of the mouse and human genomes. Genomics 1995; 29: 76972.
  • 31
    Zanke B, Squire J, Griesser H, Henry M, Suzuki H, Patterson B, Minden M, Mak TW. A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. Leukemia 1994; 8: 23644.
  • 32
    Pimkhaokhan A, Shimada Y, Fukuda Y, Kurihara N, Imoto I, Yang ZQ, Imamura M, Nakamura Y, Amagasa T, Inazawa J. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn J Cancer Res 2000; 11: 112633.
  • 33
    de la Guardia C, Casiano CA, Trinidad-Pinedo J, Baez A. CENPF gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck 2001; 23: 10412.